Michael Fluck
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Ophthalmology top 2%
- Ocular Oncology and Treatments
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 10
- Cutaneous Melanoma Detection and Management 7
- CAR-T cell therapy research 6
-
- Immunotherapy and Immune Responses 6
- Co-authors
- Lisa Zimmer (8 shared papers)Axel Hauschild (6 shared papers)Dirk Schadendorf (4 shared papers)Claus Garbe (5 shared papers)Thomas Eigentler (6 shared papers)Arndt Vogel (1 shared paper)Matthias Pauschinger (1 shared paper)Jan Leipe (1 shared paper)
- Journals
- Annals of Oncology (4 papers)The Lancet (3 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (3 papers)PLoS ONE (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Michael Fluck
28 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 71
- Oncology 1.1k
- Ophthalmology 230
- Immunology 361
- Genetics 114
- Molecular Biology 603
Countries citing papers authored by Michael Fluck
This map shows the geographic impact of Michael Fluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fluck more than expected).
Fields of papers citing papers by Michael Fluck
This network shows the impact of papers produced by Michael Fluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fluck. The network helps show where Michael Fluck may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Fluck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 416 | |
| 2 | 2015 | 213 | |
| 3 | 2020 | 197 | |
| 4 | 2016 | 191 | |
| 5 | 2019 | 186 | |
| 6 | 2018 | 181 | |
| 7 | 2022 | 84 | |
| 8 | 2002 | 75 | |
| 9 | 2015 | 61 | |
| 10 | 2023 | 50 | |
| 11 | 2018 | 32 | |
| 12 | 2019 | 17 | |
| 13 | 2015 | 17 | |
| 14 | 2008 | 15 | |
| 15 | 2007 | 12 | |
| 16 | 2005 | 10 | |
| 17 | 2016 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2004 | 8 | |
| 20 | 2017 | 6 |
About Michael Fluck
Michael Fluck is a scholar working on Oncology, Immunology, Ophthalmology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 30 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cutaneous Melanoma Detection and Management (7 papers), Melanoma and MAPK Pathways (7 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (6 papers), vaccines and immunoinformatics approaches (2 papers), Nonmelanoma Skin Cancer Studies (2 papers) and Ocular Oncology and Treatments (2 papers). The work is most often cited by research in Oncology (1.1k citations), Ophthalmology (230 citations), Immunology (361 citations), Genetics (114 citations) and Molecular Biology (603 citations). Michael Fluck has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Lisa Zimmer, Axel Hauschild, Dirk Schadendorf, Claus Garbe, Thomas Eigentler, Arndt Vogel, Matthias Pauschinger, Jan Leipe, Lucie Heinzerling and Jessica Cecile Hassel. Their work appears in journals such as Annals of Oncology, The Lancet, JDDG Journal der Deutschen Dermatologischen Gesellschaft, PLoS ONE and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.